A Study of Oral Sapacitabine and Oral Seliciclib in Patients With Advanced Solid Tumors
Condition(s):Advanced Solid TumorsLast Updated:December 22, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Advanced Solid TumorsLast Updated:December 22, 2021Completed
Condition(s):Breast CancerLast Updated:March 18, 2024Active, not recruiting
Condition(s):Leukemias; Myelodysplastic SyndromesLast Updated:December 13, 2021Completed
Condition(s):Non-small Cell Lung CancerLast Updated:December 22, 2021Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:June 22, 2022Completed
Condition(s):Cutaneous T-cell Lymphoma (CTCL)Last Updated:December 22, 2021Terminated
Condition(s):Acute Myeloid Leukemia; Myelodysplastic SyndromesLast Updated:July 16, 2019Unknown status
Condition(s):LeukemiaLast Updated:September 6, 2019Terminated
Condition(s):Acute Myeloid LeukemiaLast Updated:March 29, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.